본문 바로가기
KERD
논문KCI 등재

紫河車 藥鍼이 βA로 誘導된 Alzheimer's Disease 病態 모델에 미치는 影響

The Effects of Hominis Placenta Herbal-Acupuncture Solution on the Alzheimer's Disease Model Induced by βA

1

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류한의학

초록

Objective: Hominis Placenta is used in many cure, mainly treats a weak, chronic disease, especially senile. This research investigates the effect of the Hominis Placenta Herbal-Acupuncture Solution on Alzheimer's disease. Method: The effects of the Hominis Placenta Herbal-Acupuncture Solution on (1) IL-1β protein, TNF-α protein, MDA, and CD68/CD11b (2) the behavior (3) the infarction area of the hippocampus, and brain tissue injury in Alzheimer's diseased mice induced with βA were investigated. Results: 1. For the Hominis Placenta Herbal-Acupuncture Solution group a significant inhibitory effect on the memory deficit was shown for the mice with Alzheimer's disease induced by βA in the Morris water maze experiment, which measured stop-through latency, and distance movement-through latency. 2. The Hominis Placenta Herbal-Acupuncture Solution group suppressed the over-expression of IL-1β protein, TNF-α protein, MDA, and CD68/CD11b, in the mice with Alzheimer's disease induced by βA. 3. The Hominis Placenta Herbal-Acupuncture Solution group reduced the infarction area of hippocampus, and controlled the injury of brain tissue in the mice with Alzheimer's disease induced by βA. 4. The Hominis Placenta Herbal-Acupuncture Solution group reduced the Tau protein, GFAP protein, and presenilin1/2 protein, beta-secretase protein, (immunohistochemistry) of hippocampus in the mice with Alzheimer's disease induced by βA. Conclusion: These results suggest that the Hominis Placenta Herbal-Acupuncture Solution group may be effective for the prevention and treatment of Alzheimer's disease. Investigation into the clinical use of the Hominis Placenta Herbal-Acupuncture Solution for Alzheimer's disease is suggested for future research. Objective: Hominis Placenta is used in many cure, mainly treats a weak, chronic disease, especially senile. This research investigates the effect of the Hominis Placenta Herbal-Acupuncture Solution on Alzheimer's disease. Method: The effects of the Hominis Placenta Herbal-Acupuncture Solution on (1) IL-1β protein, TNF-α protein, MDA, and CD68/CD11b (2) the behavior (3) the infarction area of the hippocampus, and brain tissue injury in Alzheimer's diseased mice induced with βA were investigated. Results: 1. For the Hominis Placenta Herbal-Acupuncture Solution group a significant inhibitory effect on the memory deficit was shown for the mice with Alzheimer's disease induced by βA in the Morris water maze experiment, which measured stop-through latency, and distance movement-through latency. 2. The Hominis Placenta Herbal-Acupuncture Solution group suppressed the over-expression of IL-1β protein, TNF-α protein, MDA, and CD68/CD11b, in the mice with Alzheimer's disease induced by βA. 3. The Hominis Placenta Herbal-Acupuncture Solution group reduced the infarction area of hippocampus, and controlled the injury of brain tissue in the mice with Alzheimer's disease induced by βA. 4. The Hominis Placenta Herbal-Acupuncture Solution group reduced the Tau protein, GFAP protein, and presenilin1/2 protein, beta-secretase protein, (immunohistochemistry) of hippocampus in the mice with Alzheimer's disease induced by βA. Conclusion: These results suggest that the Hominis Placenta Herbal-Acupuncture Solution group may be effective for the prevention and treatment of Alzheimer's disease. Investigation into the clinical use of the Hominis Placenta Herbal-Acupuncture Solution for Alzheimer's disease is suggested for future research.

Abstract

Objective: Hominis Placenta is used in many cure, mainly treats a weak, chronic disease, especially senile. This research investigates the effect of the Hominis Placenta Herbal-Acupuncture Solution on Alzheimer's disease. Method: The effects of the Hominis Placenta Herbal-Acupuncture Solution on (1) IL-1β protein, TNF-α protein, MDA, and CD68/CD11b (2) the behavior (3) the infarction area of the hippocampus, and brain tissue injury in Alzheimer's diseased mice induced with βA were investigated. Results: 1. For the Hominis Placenta Herbal-Acupuncture Solution group a significant inhibitory effect on the memory deficit was shown for the mice with Alzheimer's disease induced by βA in the Morris water maze experiment, which measured stop-through latency, and distance movement-through latency. 2. The Hominis Placenta Herbal-Acupuncture Solution group suppressed the over-expression of IL-1β protein, TNF-α protein, MDA, and CD68/CD11b, in the mice with Alzheimer's disease induced by βA. 3. The Hominis Placenta Herbal-Acupuncture Solution group reduced the infarction area of hippocampus, and controlled the injury of brain tissue in the mice with Alzheimer's disease induced by βA. 4. The Hominis Placenta Herbal-Acupuncture Solution group reduced the Tau protein, GFAP protein, and presenilin1/2 protein, beta-secretase protein, (immunohistochemistry) of hippocampus in the mice with Alzheimer's disease induced by βA. Conclusion: These results suggest that the Hominis Placenta Herbal-Acupuncture Solution group may be effective for the prevention and treatment of Alzheimer's disease. Investigation into the clinical use of the Hominis Placenta Herbal-Acupuncture Solution for Alzheimer's disease is suggested for future research. Objective: Hominis Placenta is used in many cure, mainly treats a weak, chronic disease, especially senile. This research investigates the effect of the Hominis Placenta Herbal-Acupuncture Solution on Alzheimer's disease. Method: The effects of the Hominis Placenta Herbal-Acupuncture Solution on (1) IL-1β protein, TNF-α protein, MDA, and CD68/CD11b (2) the behavior (3) the infarction area of the hippocampus, and brain tissue injury in Alzheimer's diseased mice induced with βA were investigated. Results: 1. For the Hominis Placenta Herbal-Acupuncture Solution group a significant inhibitory effect on the memory deficit was shown for the mice with Alzheimer's disease induced by βA in the Morris water maze experiment, which measured stop-through latency, and distance movement-through latency. 2. The Hominis Placenta Herbal-Acupuncture Solution group suppressed the over-expression of IL-1β protein, TNF-α protein, MDA, and CD68/CD11b, in the mice with Alzheimer's disease induced by βA. 3. The Hominis Placenta Herbal-Acupuncture Solution group reduced the infarction area of hippocampus, and controlled the injury of brain tissue in the mice with Alzheimer's disease induced by βA. 4. The Hominis Placenta Herbal-Acupuncture Solution group reduced the Tau protein, GFAP protein, and presenilin1/2 protein, beta-secretase protein, (immunohistochemistry) of hippocampus in the mice with Alzheimer's disease induced by βA. Conclusion: These results suggest that the Hominis Placenta Herbal-Acupuncture Solution group may be effective for the prevention and treatment of Alzheimer's disease. Investigation into the clinical use of the Hominis Placenta Herbal-Acupuncture Solution for Alzheimer's disease is suggested for future research.

참고문헌 (84)

  1. 金知赫, "東醫精神醫學", pp.256~271 (1992), 現代醫學書籍社
  2. 이가옥, "노인생활실태 분석 및 정책과제", pp.114~132 (1994), 한국보건사회연구원
  3. Altstiel LD, , Prog. Neuro. Psychopharmacol. Biol. Psychiat, 15, pp.481~495 (1991)
  4. Alzheimer's Disease Collaboratory Group, "The structure of the presenilin 1(S182) gene and identification of six novel mutations in early onset AD families", Nature Genetics, 11, pp.219~222 (1995)
  5. 郭隆璨, "圖解腦神經外科學", pp.27~31 (1992), 第一醫學社
  6. 李定均, "精神醫學", pp.87~88 (1995), 一潮閣
  7. 이근후, "최신임상정신의학", pp.138~ (1988), 하나의학사
  8. 徐舜圭, "老人病學", pp.225~228 (1992), 고려의학
  9. 이광우, "임상신경학", pp.199~210 (1997), 고려의학
  10. Borchelt, D. R., "Familial Alzheimers Disease-Linked Presenilin 1 Variants Elevate A 1-42", 1-40 Ratio in Vitro and In Vivo, 1996, pp.17, 1005~1013
  11. Breakfield XO, "Gene transfer into the nervous system", Mol Neurobiol, 1, pp.339~371 (1989)
  12. Breakfield XO, "Herpes simplex virus for gene delivery to neurons", New Biol, 3, pp.203~218 (1991)
  13. Kandel E. R., "Principles of Neural Science" (1991)
  14. Kowall NW, "An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance", P. Proc. Natl. Acad. Sci., 통권 : 88, pp.7247~7251 (1991)
  15. Selkoe DJ, , N. Engl. J. Med, 320, pp.1484~1487 (1989)
  16. Selkoe DJ, , Scientific American, pp.68~72 (1991)
  17. Yankner BA, "Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease", ~ (1989)
  18. Yoo-Hun Suh, "An etiological role of amyloidogenic carboxyl-terminal fragments of the b-amyloid precursor protein in Alzhiemr's disease", J. Neurochem
  19. Weinstein HC, "Neuroimaging in the diagnosis of Alzheimer's disease II. Positron and sigle photon emission tomography", clinical Neuro. Neurosurg, 95, pp.81~91 (1993)
  20. Baddeley A.D., "The decline of working memeory in Alzheimer's disease", Brain, 114, pp.2521~2542 (1991)
  21. Borchelt DR, "Familial Alzheimer's diease-linked presenilin 1 variants elevate Aβ1-42", 1-40 ratio in vitro and in vivo, 1996, pp.17, 1005~1013
  22. Whitehouse PJ, "Alzheimer's disease and senile dementia. loss of neurons in the basal forebrain", Science, 215(4537), pp.1237~1239 (1982)
  23. Lemere CA, "The E280A presenilin 1 Alzheimer mutation produces increased Aβ 42 deposition and severe cerebellar pathology", Nat Med, 2(10), pp.1146~1150 (1996)
  24. McGeer EG, "The importance of inflammatory mechanisms in Alzheimer disease", Exp Gerontol, 33(5), pp.371~378 (1998)
  25. Tabaton M, "Senile plaques in cerebral amyloid angiopathy show accumulation of amyloid precursor protein without cytoskeletal abnormalities", Brain Res, 593(2), pp.299~303 (1992)
  26. Dickson DW, "Immunocytochemistry of neurofibrillary tangles with antibodies to subregions of tau protein, identification of hidden and cleaved tau epitopes and a new phosphorylation site", Acta Neuropathol(Berl), 84(6), pp.596~605 (1992)
  27. 장종범, "자하거에 대한 고찰", 대한한의학회지, 3(5), pp.36~38 (1965)
  28. 全國韓醫科大學本草學敎授, "本草學", pp.567~568 (1991), 永林社
  29. 이상길, "자하거 약침 제제에 대한 고찰", 대한침구학회지, 17(1), pp.67~74 (2000)
  30. 이문호, "약침요법", pp.17~24 (1999), 일중사
  31. 천영실, "약침요법의 자침부위별 흡수에 관한 연구", 대한침구학회지, 12(1), pp.302~309 (1995)
  32. 金聖賢, "洗心湯이 腦組織의 酸化作用에 미치는 影響", 동의신경정신과학회지, 8(2), pp.39~50 (1997)
  33. 鄭仁哲, "溫膽湯이 腦組織의 酸化作用에 미치는 影響", 동의신경정신과학회지, 8(2), pp.51~62 (1997)
  34. 徐元熙, "還少丹이 腦組織의 酸化作用에 미치는 影響", 동의신경정신과학회지, 9(1), pp.45~58 (1998)
  35. 金保冏, "蔘茸地黃湯이 腦組織의 酸化作用에 미치는 影響", 동의신경정신과학회지, 9(1), pp.59~72 (1998)
  36. 손정석, "七福飮이 老化 생쥐 腦組織의 生化學的 變化에 미치는 影響", 동의신경정신과학회지, 8(2), pp.25~38 (1997)
  37. 朴鍾雲, "四物湯이 老化 생쥐 腦組織의 生化學的 變化에 미치는 影響", 대한한방내과학회지, 19(1), pp.185~201 (1998)
  38. 崔龍埈, "定志丸이 腦組織의 生化學的 變化와 神經細胞의 損傷에 미치는 實驗的 硏究", 대한한의학회지, 19(1), pp.382~409 (1998)
  39. 이상룡, "安神淸腦湯이 알츠하이머질환 병태 모델의 생화학적 변화 및 기억에 미치는 영향", 동의생리병리학회지, 15(5), pp.708~722 (2001), 대한동의병리학회
  40. 정인철, "導痰益氣活血湯이 알츠하이머 질환 병태 모델의 생화학적 변화 및 기억에 미치는 영향", 동의생리병리학회지, 15(2), pp.260~276 (2001)
  41. 하수영, "加減固本丸이 치매병태모델에 미치는 영향", 동의신경정신과학회지, 13(1), pp.53~77 (2002)
  42. 윤상학, "香附子가 치매병태모델에 미치는 영향", 동의신경정신과학회지, 14(1), pp.59~74 (2003)
  43. 김현수, "巴戟天이 치매병태모델에 미치는 영향", 동의신경정신과학회지, 14(1), pp.45~58 (2003)
  44. 이채우, "紫河車 藥鍼의 구안와사에 대한 임상적 연구", 석사, pp.2005
  45. 권강, "紫河車 藥鍼치료를 이용한 양측 동시성 Bell's palsy 환자 1례에 대한 증례보고", 대한약침학회지, 6(2), pp.137~147 (2003)
  46. 윤정훈, "紫河車 藥鍼의 Bell's palsy에 대한 치험보고", 대한약침학회지, 3(1), pp.88~99 (2000)
  47. 윤현민, "紫河車 藥鍼이 睡眠障碍에 미치는 效果", 대한약침학회지, 8(1), pp.5~12 (2005), 대한약침학회
  48. 김은곤, "자하거 약침 투여후 기침가래 증상이 호전된 폐렴 후유증 환자 2례", 대한약침학회지, 6(3), pp.65~73 (2003)
  49. 임지택, "자하거 약침이 천식모델 생쥐의 면역세포 및 사이토카인에 미치는 영향", 석사, pp.2005
  50. 육태환, "홍화자·녹용·자하거 약침이 골다공증에 미치는 영향", 대한침구학회지, 18(1), pp.61~75 (2001)
  51. Jae-Yeun Lim, "A Study on Bone Resorption and Osteoporosis by Honghwain-Jahage extracts", 대한한방부인과학회지, 16(1), pp.101~117 (2003)
  52. 최창우, "가수분해물이 5-Fluorouracil 매개성 골수부전 개선에 미치는 영향", 박사, pp.2003
  53. 이은경, "자하거가 치매병태 모델의 생화학적 변화 및 행동에 미치는 영향", 석사, pp.2006
  54. 安榮基, "經穴學叢書", pp.694~ (2000), 성보사
  55. Means LW, "Glucose minimally attenuates scopolamine-but not morphine-induced deficits on a water maze alternation task", J Neural Transm, 105(10), pp.1171~1185 (1998)
  56. Yamazaki M, "FR121196, a potential antidemntia drug, ameliorates the impaired memory of rat in the Morris water maze", J Phamacol Exp Ther, 272(1), pp.256~263 (1995)
  57. Michael LH, "Ballantyne CM. Myocardial ischemia and reperfusion; a murine model", Am J physiol, 269, pp.2147~2154 (1995)
  58. 金字哲, "統計學槪論", pp.177~179 (1990), 英志文化史
  59. Swash M, , Clinical Neurology, 1, pp.120~129 (1991)
  60. Refolo LM, "Nerve and epidermal growth factors induce the release of the Alzhiemer amyoid precursor form PC12 cell cultures", Biochem Biophys Res Commun, 164, pp.664~670 (1989)
  61. Gridley KE, "Low concentrations of estradiol reduce beta-amyloid(25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells", Brain Res, 778(1), pp.158~165 (1997)
  62. Kim HS, "Carboxyl-terminal fragment of Alzheimer’s APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity", FASEB J, 14(11), pp.1508~1517 (2000)
  63. ethanol hydrochloride (T - 588), a novel cognitive enhancer, on noradrenaline release in rat cerebral cortical slices, "Biochem Pharmacol", 1997, 1263~1269
  64. Foster NL, "An enriched-population, double-blind, placebo-controlled, crossover study of tacrine and lecithin in Alzheimer's disease", Dementia, 7(5), pp.260~266 (1996)
  65. Raskind MA, "Effect of tacrine on language, praxis, and noncognitive behavioral problems in Alzheimer disease", Arch Neurol, 54(7), pp.836~840 (1997)
  66. Pyo H, "Gangliosides activate cultured rat brain microglia", J Biol Chem, 274(49), pp.34584~34589 (1999)
  67. Hunot S, "FcepsilonRⅡ", CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells, 1999, pp.19(9), 3440~3447
  68. Stephen LY, "Amyloid β and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia", J Neurochem, 74(3), pp.1017~1025 (2000)
  69. Zhao W, "TNF-alpha induced over-expression of GFAP is associated with MAPKs", Neuroreport, 11(2), pp.409~412 (2000)
  70. 張介賓, "張氏景岳全書", pp.610~611 (1978), 翰成社
  71. 陳士澤, "國譯石室秘錄", pp.102~ (1984), 書苑堂
  72. 洪元植, "精校黃帝內經素問", pp.217~218 (1985), 동양의학연구원
  73. 黃大東, "實用中醫內科學", pp.378~381 (1989), 上海科學技術出版社
  74. 辛民敎, "臨床本草學", pp.191~192 (1997), 永淋社
  75. 대한약침학회, "약침요법 시술 지침서", pp.182~ (1992), 한성인쇄
  76. H. Nakaya, "Electrophysiological derangements induced by lipid peroxidation in cardiac tissue", Am J Physiol Heart Circ Physiol, 253, pp.H1089~H1097 (1987)
  77. Tappel AL, "Lipid peroxidation damage to cell components", Fed Proc, 통권 : 32, pp.1870~1874 (1973)
  78. Kanter M, "exercise and antioxidant supplementation", Proc Nutr Soc, 통권 : 57, pp.9~13 (1998)
  79. Maxwell MB, "Cancer of the prostate", Semin Oncol Nurs, 9(4), pp.237~251 (1993)
  80. Viguie CA, "Antioxidant status and indexes of oxidative stress during consecutive days of exercise", J Appl Physiol, 75(2), pp.566~572 (1993)
  81. Chong YH, "Effect of a carboxy-terminal fragment of Alzheimer's amyloid precursor protein on expression of proinflammatory cytokines in rat glial cells", Life Sciences, 61(23), pp.2323~2333 (1997)
  82. Araujo DM, "Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease", Brain Res, 569(1), pp.141~145 (1992)
  83. Lassmann H, "Cell death in Alzheimer‘s disease evaluated by DNA fragmentation in situ", Acta Neuropathol(Berl), 89, pp.35~41 (1995)
  84. Troncoso JC, "In situ labeling of dying cortical neurons in normal aging and in Alzheimer‘s disease, correlations with senile plaques and disease progression", J Neuropathol Exp Neurol, 55, pp.1134~1142 (1996)

관련 논문AI추천

이 간행물의 다른 논문 (22건)